NASDAQ:ISPC - Nasdaq - US45032V2079 - Common Stock - Currency: USD
Overall ISPC gets a fundamental rating of 1 out of 10. We evaluated ISPC against 35 industry peers in the Health Care Technology industry. ISPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ISPC has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -133.66% | ||
ROE | -377.46% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 42.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -14.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.62 | ||
Quick Ratio | 0.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
1.47
+0.23 (+18.55%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.4 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.11 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -133.66% | ||
ROE | -377.46% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 42.92% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 29.85% | ||
Cap/Sales | 7.37% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.62 | ||
Quick Ratio | 0.62 | ||
Altman-Z | -14.23 |